Allergy Therapeutics
AGY.L
#7396
Rank
NZ$0.53 B
Marketcap
$0.11
Share price
-5.45%
Change (1 day)
237.31%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2023: -NZ$89.8 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are NZ$75.16 Million. In 2023 the company made an earning of -NZ$89.8 Million a decrease over its 2022 earnings that were of -NZ$26.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2023

Annual earnings

Year Earnings Change
2023-NZ$89.8 Million243.12%
2022-NZ$26.18 Million-403.33%
2021NZ$8.62 M-49.05%
2020NZ$16.93 M82.31%
2019NZ$9.28 M-159.83%
2018-NZ$15.53 Million255.37%
2017-NZ$4.37 Million-84.22%
2016-NZ$27.69 Million-1678.94%
2015NZ$1.75 M-44.28%
2014NZ$3.14 M129.45%
2013NZ$1.37 M-19.85%
2012NZ$1.71 M-127%
2011-NZ$6.34 Million2044.94%
2010-NZ$0.3 Million-99.08%
2009-NZ$32.11 Million-53.32%
2008-NZ$68.77 Million-21.76%
2007-NZ$87.9 Million351.81%
2006-NZ$19.46 Million230.51%
2005-NZ$5.89 Million-219.33%
2004NZ$4.93 M-58.79%
2003NZ$11.97 M-196.03%
2002-NZ$12.47 Million